[go: up one dir, main page]

MX2014002630A - Produccion de alcaloides sin el aislamiento de compuestos intermediarios. - Google Patents

Produccion de alcaloides sin el aislamiento de compuestos intermediarios.

Info

Publication number
MX2014002630A
MX2014002630A MX2014002630A MX2014002630A MX2014002630A MX 2014002630 A MX2014002630 A MX 2014002630A MX 2014002630 A MX2014002630 A MX 2014002630A MX 2014002630 A MX2014002630 A MX 2014002630A MX 2014002630 A MX2014002630 A MX 2014002630A
Authority
MX
Mexico
Prior art keywords
alkaloids
intermediates
isolation
production
processes
Prior art date
Application number
MX2014002630A
Other languages
English (en)
Inventor
Tao Jiang
Peter X Wang
David W Berberich
Original Assignee
Mallinckrodt Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Llc filed Critical Mallinckrodt Llc
Publication of MX2014002630A publication Critical patent/MX2014002630A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Addiction (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a procesos para la producción de alcaloides sin el aislamiento de compuesto intermediarios.
MX2014002630A 2011-09-08 2012-09-07 Produccion de alcaloides sin el aislamiento de compuestos intermediarios. MX2014002630A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161532253P 2011-09-08 2011-09-08
PCT/US2012/054099 WO2013036729A1 (en) 2011-09-08 2012-09-07 Production of alkaloids without the isolation of intermediates

Publications (1)

Publication Number Publication Date
MX2014002630A true MX2014002630A (es) 2014-04-14

Family

ID=46982922

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014002630A MX2014002630A (es) 2011-09-08 2012-09-07 Produccion de alcaloides sin el aislamiento de compuestos intermediarios.

Country Status (14)

Country Link
US (1) US8624031B2 (es)
EP (1) EP2753622B1 (es)
JP (1) JP2014526467A (es)
KR (1) KR20140063763A (es)
CN (1) CN103917543A (es)
AU (1) AU2012304484B2 (es)
BR (1) BR112014005421A2 (es)
CA (1) CA2845187A1 (es)
ES (1) ES2566620T3 (es)
IL (1) IL231292A0 (es)
MX (1) MX2014002630A (es)
PL (1) PL2753622T3 (es)
RU (1) RU2014112493A (es)
WO (1) WO2013036729A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6161801B2 (ja) 2013-05-24 2017-07-12 ローズ テクノロジーズ オピオイドケタール化合物及びその使用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE922827C (de) 1951-02-08 1955-01-27 Knoll Ag Verfahren zur Herstellung von quartaeren Ammoniumsalzen, die 2 Tetrahydroisochinolinreste enthalten
US2772270A (en) 1954-10-21 1956-11-27 M J Lewenstein 14-hydroxymorphinone and 8, 14-dihydroxydihydromorphinone
DE1119284B (de) 1959-09-02 1961-12-14 Boehringer Sohn Ingelheim Verfahren zur Herstellung von antagonistisch gegen Morphin und schmerzstillend wirkenden quartaeren Salzen des Normorphins und deren acylierten Derivaten
FR1602610A (en) 1962-10-10 1971-01-04 10.10.62.-17.4.63. 38445-15209 thebaine derivs
US3438989A (en) 1967-03-10 1969-04-15 Warner Lambert Pharmaceutical Process for the production of ( ) dihydrothebainone
US3717643A (en) 1967-05-04 1973-02-20 Sterling Drug Inc N-substituted-norapomorphines
FR2189403A1 (en) 1972-06-15 1974-01-25 Merck & Co Inc Norcodeine prepn - by reduction of 1-halo-norcodeinones, novel intermedi-ates for narcotic antagonists
US4089855A (en) 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby
EP0034480A3 (en) 1980-02-14 1982-01-13 Grigg, Ronald Ernest Alkylation of amines
US4368326A (en) 1980-07-03 1983-01-11 Rice Kenner C Short total synthesis of dihydrothebainone, dihydrocodeinone, and nordihydroccodeinone
US4521601A (en) 1981-05-20 1985-06-04 The United States Of America As Represented By The Department Of Health & Human Services Practical total synthesis unnatural enantiomers of opium-derived morphinans
US4795813A (en) 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US4443605A (en) 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
DE3581423D1 (de) 1984-03-27 1991-02-28 Mallinckrodt Inc Herstellung von noroxymorphon aus morphin.
HU197750B (en) 1984-07-17 1989-05-29 Alkaloida Vegyeszeti Gyar Process for n-demethylation of morphine alkaloids
US4775759A (en) 1984-11-27 1988-10-04 The United States Of America As Represented By The Department Of Health And Human Services Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
US4673679A (en) 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US5668285A (en) 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
US4912114A (en) 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives
US4991391A (en) 1989-01-27 1991-02-12 Westinghouse Electric Corp. System for cooling in a gas turbine
PT95069B (pt) 1989-08-24 1997-10-31 Searle & Co Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos
US5208338A (en) 1991-06-14 1993-05-04 The United States Of America As Represented By The Department Of Health & Human Services. Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans
DE4132159A1 (de) 1991-09-27 1993-04-01 Boehringer Ingelheim Kg 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphin und -norisomorphin, verfahren zu deren herstellung und deren verwendung als arzneimittel
CH683005A5 (it) 1991-10-30 1993-12-31 Aldo Massarotti Procedimento per la preparazione, mediante ossidazione di N-ossidi per le terapie dei tossicomani da oppiati.
DK0577847T3 (da) 1992-01-23 1999-06-23 Toray Industries Morphinanderivat og medicinsk anvendelse deraf
AU683664B2 (en) 1993-06-30 1997-11-20 Toray Industries, Inc. Antitussive
US5756745A (en) 1994-05-31 1998-05-26 Mallinckrodt Medical, Inc. Preparation of nalbuphine having low levels of β-epimer
CN1045442C (zh) 1994-07-20 1999-10-06 中国科学院上海药物研究所 左、右旋氯斯库利啉及它的制备方法和用途
DE69635874T2 (de) 1995-12-06 2006-12-14 Japan Science And Technology Agency, Kawaguchi Verfahren zur Herstellung von optisch aktiven Alkoholen
DE19548399A1 (de) 1995-12-22 1997-06-26 Basf Ag Rutheniumkomplexe mit einem chiralen, zweizähnigen Phosphinoxazolin-Liganden zur enantioselektiven Transferhydrierung von prochiralen Ketonen
GB9616253D0 (en) 1996-08-01 1996-09-11 Johnson Matthey Plc Preparation of narcotic analgesics
ES2215158T3 (es) 1996-11-25 2004-10-01 Toray Industries, Inc. Agente antipruritico.
PT102006B (pt) 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
WO1999042105A1 (en) 1998-02-20 1999-08-26 Avmax, Inc. Epimorphian compound and its use
GB9821067D0 (en) 1998-09-29 1998-11-18 Zeneca Ltd Transfer hydrogenation process
WO2001014382A1 (en) 1999-08-23 2001-03-01 Toray Industries, Inc. Analgesics containing as the active ingredient quaternary ammonium salt derivatives of morphinan
WO2001074819A1 (en) 2000-04-03 2001-10-11 Toray Industries, Inc. Analgesics containing morphinan n-oxide derivatives as the active ingredient
JP4024992B2 (ja) 2000-04-27 2007-12-19 オリバー ヤオ−プ フ ポリナルブフィン誘導体及びそれを製造するための方法
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
PL368732A1 (en) 2001-08-23 2005-04-04 Akzo Nobel N.V. C-14 oxidation of morphine derivatives
DE10229842A1 (de) 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
DE60329520D1 (de) 2002-11-08 2009-11-12 Mallinckrodt Inc Verfahren zur herstellung von quaternäre n-alkyl morphinan alkaloid salzen
WO2004082620A2 (en) 2003-03-13 2004-09-30 Controlled Chemicals, Inc. Oxycodone conjugates with lower the abuse potential and extended duration of action
CA2520030A1 (en) 2003-03-26 2004-10-07 Pharmacia & Upjohn Company Llc Process to produce enantiomerically enriched alcohols and amines
HUE034668T2 (hu) 2003-09-22 2018-02-28 Glaxosmithkline Australia Pty Ltd Eljárás morfinán-származékok szintézisére és azok intermedierjei
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
SK286047B6 (sk) 2004-04-13 2008-01-07 Zentiva, A. S. Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
US6887999B1 (en) 2004-05-21 2005-05-03 Acura Pharmaceuticals, Inc. Preparation of dihydrocodeine from codeine
CA2574362A1 (en) 2004-07-23 2006-01-26 Pliva-Istrazivanje I Razvoj D.O.O. Process
GB0421687D0 (en) * 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
RU2415131C2 (ru) 2004-11-05 2011-03-27 Ренссилэйер Политекник Инститьют 4-гидроксибензоморфаны
CN101171010B (zh) 2005-03-07 2014-09-17 芝加哥大学 阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途
AU2006234257B2 (en) 2005-04-06 2011-03-10 Toray Industries, Inc. Crystals of morphinan derivative and process for producing the same
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
EP1959956A2 (en) 2005-12-15 2008-08-27 Naturemed Group Corporation Sinomenine derivatives and preparation and uses thereof
US20100022774A1 (en) 2006-05-25 2010-01-28 Ole Heine Kvernenes Process useful in the preparation of morphinan antagonists
ATE517869T1 (de) 2006-09-20 2011-08-15 Mallinckrodt Inc Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
FR2906252B1 (fr) 2006-09-21 2008-11-28 Sanofi Aventis Sa Procede de preparation d'halogenures de n-aklyl naltrexone
WO2008136865A2 (en) 2006-11-22 2008-11-13 Progenics Pharmaceuticals, Inc. (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
AU2007323718A1 (en) 2006-11-22 2008-05-29 Progenics Pharmaceuticals, Inc. Processes for synthesizing quaternary 4,5-epoxy-morphinan analogs and isolating their N-stereoisomers
CA2670342A1 (en) 2006-11-22 2008-06-12 Progenics Pharmaceuticals, Inc. N-oxides of 4,5-epoxy-morphinanium analogs
MX2009005462A (es) 2006-11-22 2009-08-28 Progenics Pharm Inc Analogos de 7,8-saturados-4,5-epoxi-morfinano.
EP2222642B1 (en) 2007-12-17 2014-02-12 Mallinckrodt LLC Process and compounds for the production of (+) opiates
WO2010033442A1 (en) * 2008-09-16 2010-03-25 Mallinckrodt Inc. Processes for the synthesis of five and six membered heterocyclic rings
CN102227434B (zh) 2008-09-30 2015-02-18 马林克罗特有限公司 选择性胺化酮吗啡喃的方法
CN102325776A (zh) 2009-02-23 2012-01-18 马林克罗特公司 (+)-吗啡喃*季盐及其制备方法

Also Published As

Publication number Publication date
ES2566620T3 (es) 2016-04-14
US20130066080A1 (en) 2013-03-14
EP2753622A1 (en) 2014-07-16
AU2012304484B2 (en) 2016-07-28
IL231292A0 (en) 2014-04-30
EP2753622B1 (en) 2016-01-20
CN103917543A (zh) 2014-07-09
AU2012304484A1 (en) 2014-02-27
US8624031B2 (en) 2014-01-07
WO2013036729A1 (en) 2013-03-14
RU2014112493A (ru) 2015-10-20
BR112014005421A2 (pt) 2017-04-04
JP2014526467A (ja) 2014-10-06
PL2753622T3 (pl) 2016-07-29
KR20140063763A (ko) 2014-05-27
CA2845187A1 (en) 2013-03-14

Similar Documents

Publication Publication Date Title
PT2744768T (pt) Processo para a produção de clínquer de ternesite
MD20150091A2 (ro) Compuşi antivirali
GB201103836D0 (en) Conjugation process
HK1204604A1 (en) Stereoselective total synthesis of noribogaine
ZA201308446B (en) Process for the production of estetrol intermediates
MX2013015147A (es) Procesos y compuestos intermediarios para producir azaindoles.
MX2015002487A (es) Proceso para la preparacion de teneligliptina.
ZA201308445B (en) Process for the production of estetrol intermediates
IN2012MU03723A (es)
MX2013007567A (es) Procedimiento para preparar poliestereteroles.
IN2014DN09450A (es)
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
ZA201205844B (en) Process for the production of anhydrides
IN2014DN09451A (es)
IN2013MU01113A (es)
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
WO2014118606A3 (en) A novel process for the preparation of silodosin
IN2014DN10209A (es)
MX2014002378A (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
WO2014102759A3 (en) Process for the preparation of dasatinib and its intermediates
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
MX2014002630A (es) Produccion de alcaloides sin el aislamiento de compuestos intermediarios.
WO2014170909A3 (en) Process for pomalidomide
IN2014DN07498A (es)
IN2014CN02645A (es)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal